tak 779 has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdulreda, MH; Bayer, AL; Berggren, PO; Caicedo, A; Echeverria, OA; Edlund, PK; Faleo, G; Leibiger, I; Lopez-Cabezas, M; Molano, RD; Molina, J; Perez, V; Pileggi, A; Ricordi, C; Rodriguez-Diaz, R; Tan, Y; Zahr-Akrawi, E | 1 |
1 other study(ies) available for tak 779 and Alloxan Diabetes
Article | Year |
---|---|
High-resolution, noninvasive longitudinal live imaging of immune responses.
Topics: Amides; Animals; Anterior Chamber; CCR5 Receptor Antagonists; Chemokines; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Green Fluorescent Proteins; Interferon-gamma; Interleukin-2; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Microscopy, Confocal; Microscopy, Video; Quaternary Ammonium Compounds; Receptors, CCR5; Single-Cell Analysis; T-Lymphocytes; Time Factors | 2011 |